Overview Targeted drug delivery

Learn how targeted drug delivery can help you manage chronic pain.
Watch The Video

Explore the benefits of targeted drug delivery therapy 

Patients report a reduction in pain scores after receiving targeted drug delivery.1

  • 51% of patients completely eliminated other opioids* at 12 months. 2
  • 87% of patients rated their quality of life as fair to excellent. 1
  • 90% of patients would recommend therapy to a family member or friend.2

Medtronic is a worldwide leader 

Over 30 years of experience in targeted drug delivery3

Thousands of lives transformed

More than 300,000 SynchroMed™ II pumps implanted worldwide4

Alleviate unpredictable pain

Learn more

A system for pain relief

Discover how the SynchroMed™ II pump and myPTM™ Personal Therapy Manager deliver pain relief.

Find out more
Older male doctor shakes younger male patient's hand.

Allows full-body MRI scans under specific conditions

Learn about scans
*

Other opioids include systemic opioids.

MR yellow triangleUnder specific conditions. Talk to your doctor and refer to product labeling for full list of conditions.

1

Deer T, Chapple I, Classen A, et al. Intrathecal drug delivery for treatment of chronic low back pain; report from the National Outcomes Registry for Low Back Pain. Pain Med. 2004;5(1):6-13.

2

Hatheway JA, et al. Systemic opioid elimination after implantation of an intrathecal drug delivery system significantly reduced health-care expenditures. Neuromodulation. 2015 Apr;18(3):207-13.

3

Medtronic has had targeted drug delivery therapy indications approved since 1988.

4

Medtronic data on file.

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.